1. Home
  2. RDHL vs SHFS Comparison

RDHL vs SHFS Comparison

Compare RDHL & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$0.55

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

HOLD

Current Price

$0.17

Market Cap

2.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDHL
SHFS
Founded
2009
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
2.7M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
RDHL
SHFS
Price
$0.55
$0.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
424.9K
Earning Date
04-27-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
95.30
EPS
N/A
N/A
Revenue
N/A
$7,673,532.00
Revenue This Year
$381.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.14
52 Week High
$2.79
$9.18

Technical Indicators

Market Signals
Indicator
RDHL
SHFS
Relative Strength Index (RSI) 38.72 50.23
Support Level N/A N/A
Resistance Level $0.76 $0.21
Average True Range (ATR) 0.06 0.01
MACD -0.02 0.00
Stochastic Oscillator 2.07 78.65

Price Performance

Historical Comparison
RDHL
SHFS

About RDHL Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: